News & Events
-
How Do Drugs Get Approved (and Fast-Tracked) by the FDA?
Read time: 5 minutes.
This is Part 3 in our series on how drugs get approved to treat lung cancer.
-
How We Define Success for a Clinical Trial
Read time: 6 minutes. This is Part 2 of 3 in our series on how drugs get approved to treat lung cancer. Make sure to read Part 1 on the phases of clinical trials and why they are... -
Understanding Clinical Trials: Why Are They Important for Drug Development?
Read time: 3 minutes. This is Part 1 in a 3-part series explaining how new drugs and treatments get approved to treat lung cancer. Parts 2 and 3 will be published in the coming... -
Countdown to ILCSC24: Bringing the World’s Experts Right to Your Living Room
Read time: 3 minutes. One of LUNGevity’s two flagship survivorship events, the International Lung Cancer Survivorship Conference (ILCSC), is being held virtually September 20 – 21... -
How Can Patients and Researchers Design Clinical Trials Together?
Read time: 2 minutes. Traditionally, people associate getting involved in lung cancer research with enrolling in a clinical trial. But most don’t realize they can also partner with... -
2024 ASCO: Highlights of Lung Cancer Research
Read time: 8 minutes Thousands of oncologists, scientists, biotech and pharmaceutical representatives, patients, and advocates (including LUNGevity staff) met to discuss lifesaving... -
KRAS Virtual Meetup
Join us the 3rd Wednesday of every month to c onnect with others who share common experiences and build your community. After registering, you will receive a confirmation email... -
Researcher Aims to Bring 360-Degree Care to Young Adults Living with Lung Cancer
Young adults (less than 50 years of age) are being diagnosed with lung cancer at increasing rates. They tend to be women of Hispanic or Asian descent and are typically diagnosed... -
Safely Bring Yoga, Dietary Supplements, Exercise, and More into Your Lung Cancer Journey
Read time: 2 minutes Integrative oncology adds holistic approaches—such as acupuncture, nutrition, exercise, and mindfulness—into a treatment plan. Research shows these... -
Advice and Insights from Author and Two-Time Cancer Survivor Kathy Giusti
Kathy Giusti joined LUNGevity for a special conversation about her life as a cancer patient, caregiver, and the founder and former CEO of the Multiple Myeloma Research Foundation...
Laurie’s Path to Finding the Right Doctor, the Right Test, and the Right Treatment
Laurie’s Path to Finding the Right Doctor, the Right Test, and the Right Treatment
Laurie Seligman, a 57-year-old bookkeeper living in Texas, had a lingering cough, but over-the-counter cough syrup seemed to help, so she didn’t think much of it and she continued with her usual activities. One day in 2017, she hurt her back moving a heavy bed, and went to her general care doctor. She mentioned the cough and got an X-ray. After being treated for pneumonia, her symptoms subsided. She had a follow-up X-ray but was told that it was normal for the pneumonia to still be visible…
Linda I. Shares Her Story
Linda I. Shares Her Story
I was told on October 11, 2007, that I had non-small cell lung cancer (NSCLC). I was 46 years old with 2 kids — 7 and 12 year olds — at home waiting for me.I had an MRI and PET scan and had my second lung cancer diagnosis. I went to Lombardi Cancer Center in Georgetown (Washington, DC) and they took care of me. Those amazing people guided me on my journey with bilateral lung cancer.I was not aware of biomarkers back then, but I had bilateral thoracotomies and chemotherapy.I survived.…
Let Your Voice Be Heard!
Let Your Voice Be Heard!
We are collecting stories from patients, caregivers, friends, and family members! Tell us how lung cancer has affected your life. Email your story to us at support@lungevity.org. Thanks!
All About Biomarker Testing & KRAS+ Lung Cancer
All About Biomarker Testing & KRAS+ Lung Cancer
Patient Rosemary Conway was joined by LUNGevity's Dr. Amy Moore and Hatim Husain, an oncologist at UCSD, to discuss biomarker testing and progress in KRAS-positive lung cancer.